- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, November 11, 2022
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
A piece by Healio cited a study published in the September issue of The American Journal of Managed Care® (AJMC®). The study, “Physician Response to COVID-19–Driven Telehealth Flexibility for Opioid Use Disorder,” found that COVID-19-driven telehealth exposure positively shifted physician respondents’ perceptions of telehealth effectiveness, with a majority of clinicians reportedly likely to continue use if temporary telehealth regulatory flexibility is permanently extended.
A study published in the AJMC® November issue, “Improving Risk Stratification Using AI and Social Determinants of Health” was referenced by HealthITAnalytics. The study showed that prediction models combining claims data with social determinants of health and additional, more-timely data sources using artificial intelligence (AI) can better identify individuals with the highest future medical spending.
Expert Insights on How Utilization Management Drives Physician Burnout
November 26th 2024On this episode of Managed Care Cast, we speak with the author of a study published in the November 2024 issue of The American Journal of Managed Care® to explore the link between utilization management and physician burnout.
Listen
NCCN Guidelines Prioritize Quad Therapy in Multiple Myeloma
November 26th 2024In the most recent update to the National Comprehensive Cancer Network (NCCN) guidelines for treating patients who have multiple myeloma, a quadruplet regimen became the preferred first-line treatment option for transplant-eligible and -ineligible patients.
Read More
Metformin Improves Symptoms and Gene Expression in Central Centrifugal Cicatricial Alopecia
November 26th 2024Patients with treatment-resistant central centrifugal cicatricial alopecia saw improvement in symptoms and gene expression, suggesting the potential of metformin as a new treatment option.
Read More
